文献速递消化系统肿瘤

吸烟与胰腺癌生存

Cigarette Smoking and Pancreatic Cancer Survival.
PubMed 文献 · J Clin Oncol · 2017-03-30

基于两项美国大型前瞻性队列研究(1986至2013年确诊)的1,037例胰腺癌患者,分析吸烟状态与生存的关系;另在四项美国前瞻性队列的485例患者中评估诊断前循环可替宁水平与生存的关系。当前吸烟者较从不吸烟者死亡风险升高(HR 1.37,95%CI 1.11至1.69,P=.003),吸烟包年数增加与生存呈负向趋势(Ptrend=.008),诊断前可替宁水平判定的重度吸烟者死亡风险升高。

要点

  • 当前吸烟者较从不吸烟者死亡风险升高,HR 1.37(95%CI 1.11至1.69,P=.003)。
  • 吸烟包年数增加与生存呈显著负向趋势(Ptrend=.008),>60包年者较从不吸烟者HR 1.49(95%CI 1.05至2.10)。
  • 诊断前循环可替宁判定的重度吸烟者较非吸烟者死亡风险升高(HR 1.76,95%CI 1.23至2.51)。

核心结论

  • 吸烟与胰腺癌患者生存期缩短相关。

研究设计与样本

  • 分析两项美国大型前瞻性队列研究中1986至2013年确诊的1,037例胰腺癌患者的吸烟状态与生存关系。
  • 另在四项美国前瞻性队列的485例患者中评估诊断前循环可替宁水平与生存的关系。
  • 按诊断前可替宁水平分为非吸烟者(<3.1 ng/mL)、轻度吸烟者(3.1至20.9 ng/mL)、重度吸烟者(≥21.0 ng/mL)。
  • 采用Cox比例风险模型估计死亡HR,校正年龄、性别、种族/民族、体质指数、糖尿病状态、诊断年份和肿瘤分期。

主要发现

  • 当前吸烟者较从不吸烟者 multivariable 校正后死亡HR为1.37(95%CI 1.11至1.69,P=.003)。
  • 吸烟包年数增加与生存呈统计学显著负向趋势(Ptrend=.008);>60包年者较从不吸烟者死亡HR为1.49(95%CI 1.05至2.10)。
  • 戒烟者生存与从不吸烟者相似,与戒烟时间长短无关。
  • 诊断前循环可替宁判定的重度吸烟者较非吸烟者 multivariable 校正后死亡HR为1.76(95%CI 1.23至2.51)。
  • 诊断前5年内测定循环可替宁者中,重度吸烟者较非吸烟者 multivariable 校正后死亡HR为2.47(95%CI 1.24至4.92)。

关键数值与推荐

  • 当前吸烟 vs 从不吸烟:死亡HR 1.37(95%CI 1.11至1.69,P=.003)。
  • >60包年吸烟 vs 从不吸烟:死亡HR 1.49(95%CI 1.05至2.10),Ptrend=.008。
  • 诊断前可替宁判定的重度吸烟 vs 非吸烟:死亡HR 1.76(95%CI 1.23至2.51)。
  • 诊断前5年内测可替宁的重度吸烟 vs 非吸烟:死亡HR 2.47(95%CI 1.24至4.92)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose Cigarette smoking is associated with increased incidence of pancreatic cancer. However, few studies have prospectively evaluated the association of smoking with patient survival. Patients and Methods We analyzed survival by smoking status among 1,037 patients from two large US prospective cohort studies diagnosed from 1986 to 2013. Among 485 patients from four prospective US cohorts, we also evaluated survival by prediagnostic circulating levels of cotinine, a metabolite of nicotine that is proportional to tobacco smoke exposure. On the basis of prediagnosis cotinine levels, we classified patients as nonsmokers (< 3.1 ng/mL), light smokers (3.1-20.9 ng/mL), or heavy smokers (≥ 21.0 ng/mL). We estimated hazard ratios (HRs) for death by using Cox proportional hazards models, with adjustment for age, sex, race/ethnicity, body mass index, diabetes status, diagnosis year, and cancer stage. Results The multivariable-adjusted HR for death was 1.37 (95% CI, 1.11 to 1.69) comparing current smokers with never smokers ( P = .003). A statistically significant negative trend in survival was observed for increasing pack-years of smoking ( Ptrend = .008), with HR for death of 1.49 (95% CI, 1.05 to 2.10) for > 60 pack-years of smoking versus never smoking. Survival among former smokers was similar to that for never smokers, regardless of time since quitting. Heavy smokers defined by prediagnostic circulating cotinine levels had a multivariable-adjusted HR for death of 1.76 (95% CI, 1.23 to 2.51) compared with nonsmokers. Among patients with circulating cotinine levels measured within 5 years before diagnosis, heavy smokers had a multivariable-adjusted HR for death of 2.47 (95% CI, 1.24 to 4.92) compared with nonsmokers. Conclusion Cigarette smoking was associated with a reduction in survival among patients with pancreatic cancer.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Yuan C, Morales-Oyarvide V, Babic A, et al. Cigarette Smoking and Pancreatic Cancer Survival. J Clin Oncol. 2017. PMID: 28358654. doi:10.1200/JCO.2016.71.2026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。